Isolation and characterization of senescent Cryptococcus neoformans and implications for phenotypic switching and pathogenesis in chronic cryptococcosis

Eukaryot Cell. 2009 Jun;8(6):858-66. doi: 10.1128/EC.00017-09. Epub 2009 May 1.

Abstract

Although several virulence factors and associated genes have been identified, the mechanisms that allow Cryptococcus neoformans to adapt during chronic infection and to persist in immunocompromised hosts remain poorly understood. Characterization of senescent cells of C. neoformans demonstrated that these cells exhibit a significantly enlarged cell body and capsule but still cross the blood-brain barrier. C. neoformans cells with advanced generational age are also more resistant to phagocytosis and killing by antifungals, which could promote their selection during chronic disease in humans. Senescent cells of RC-2, a C. neoformans strain that undergoes phenotypic switching, manifest switching rates up to 11-fold higher than those of younger cells. Infection experiments with labeled cells suggest that senescent yeast cells can potentially accumulate in vivo. Mathematical modeling incorporating different switching rates demonstrates how increased switching rates promote the emergence of hypervirulent mucoid variants during chronic infection. Our findings introduce the intriguing concept that senescence in eukaryotic pathogens could be a mechanism of microevolution that may promote pathoadaptation and facilitate evasion of an evolving immune response.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Animals
  • Antifungal Agents / pharmacology
  • Cryptococcosis / immunology
  • Cryptococcosis / microbiology*
  • Cryptococcus neoformans / drug effects
  • Cryptococcus neoformans / isolation & purification
  • Cryptococcus neoformans / pathogenicity*
  • Cryptococcus neoformans / physiology*
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Phagocytosis
  • Phenotype

Substances

  • Antifungal Agents